D05 Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Deciphera Pharmaceuticals Inc - Alpha Spread
D

Deciphera Pharmaceuticals Inc
F:D05

Watchlist Manager
Deciphera Pharmaceuticals Inc
F:D05
Watchlist
Price: 38 EUR 0.16% Market Closed
Market Cap: 3.1B EUR
Have any thoughts about
Deciphera Pharmaceuticals Inc?
Write Note

Wall Street
Price Targets

D05 Price Targets Summary
Deciphera Pharmaceuticals Inc

Wall Street analysts forecast D05 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for D05 is 66.9 EUR .

Lowest
Price Target
Not Available
Average
Price Target
66.9 EUR
76% Upside
Highest
Price Target
Not Available
Deciphera Pharmaceuticals Inc Competitors:
Price Targets
1875
TOT BIOPHARM International Co Ltd
53% Upside
KRRO
Korro Bio Inc
224% Upside
MDG1
Medigene AG
15% Upside
TNG
Transgene SA
205% Upside
688363
Bloomage Biotechnology Corp Ltd
45% Upside
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
20% Upside
VICO
Vicore Pharma Holding AB
611% Upside
GNTA
Genenta Science SPA
611% Upside

Revenue
Forecast

Revenue Estimate
Deciphera Pharmaceuticals Inc

The compound annual growth rate of Deciphera Pharmaceuticals Inc's revenue for the next 1 year is 12%.

N/A
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Deciphera Pharmaceuticals Inc

Operating Income forecast
is not available for
Deciphera Pharmaceuticals Inc

Net Income
Forecast

Net Income Estimate
Deciphera Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is D05's stock price target?
Price Target
66.9 EUR

According to Wall Street analysts, the average 1-year price target for D05 is 66.9 EUR .

What is Deciphera Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
12%

The compound annual growth rate of Deciphera Pharmaceuticals Inc's revenue for the next 1 year is 12%.

Back to Top